Volver a Agenda
Session Chair(s)
Herng-Der Chern, MD, PHD
Chief Medical Officer
Supra Integrated and Incubation Center, Taiwan
Learning Objective : Discuss the gaps between funding and drug development know-how for commercialization in translational medicine; Describe national strategies and measures to bridge the gap using an approach like venture capital; Compare the similarities and differences among three models in Asia - namely D3 Singapore, KDDF Korea, and SIIC Taiwan.
Speaker(s)
The Stanford SPARK Model
Daria Mochly-Rosen
Stanford University, United States
Professor, Co-Director of SPARK
Singapore's D3 Model
Louise Sarup, PHD
D3, A*STAR, Singapore
Head of Business Development and Licensing
¿Tiene una cuenta?